Advances in Endometrial Cancer Prevention, Early Diagnosis and Treatment
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 20 May 2026 | Viewed by 325
Special Issue Editor
Interests: endometrial cancer; surgery; advanced therapy; molecular classification; biomarkers
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The rising global incidence of endometrial cancer means that more women than ever are living with and, unfortunately, also dying from this disease. Whilst surgery in combination with radio- and chemotherapy has long been the cornerstone of endometrial cancer treatment, increasing knowledge of endometrial cancer biology has ensured the success of fertility-sparing approaches and enabled the personalisation of care. The molecular characterisation of tumours and clinical trials of immunotherapies are set to revolutionise how we manage the disease as we move towards improving disease control whilst minimising treatment side effects.
This Special Issue aims to highlight the recent advances in the prevention, early diagnosis, and treatment of early and advanced/recurrent endometrial cancer and answer any outstanding research questions. Both original research articles and review papers are welcome to be submitted to this Special Issue.
Dr. Sarah J. Kitson
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- endometrial cancer
- gynaecologic oncology
- surgery
- prevention
- early diagnosis
- advanced therapy
- molecular classification
- biomarkers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
